Session 19: Debate: NALIRIFOX or FOLFIRINOX for Treatment-Naive Metastatic Pancreatic Cancer - Discussion

Moderator(s)

• 

  Cathy Eng, MD, FACP, FASCO

  Vanderbilt-Ingram Cancer Center
  MD Anderson Cancer Center
• 

  David H. Ilson, MD, PhD

  Weill Cornell Medical College, Memorial Hospital, Memorial Sloan Kettering Cancer Center

Panelist(s)

• 

  Jordan D. Berlin, MD

  Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
• 

  Milind M. Javle, MD

  MD Anderson Cancer Center, The University of Texas